According to ArriVent BioPharma's latest financial reports the company's current earnings (TTM) are -$62.05 M. In 2022 the company made an earning of -$36.91 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$62.05 M | 68.11% |
2022 | -$36.91 M |